Molecular features of early- vs. late-onset gastric cancer: a systematic review and meta-analysis
Preprint
- 16 May 2025
- preprint
- Published by Springer Nature in Research Square
Abstract
Background: Early-onset gastric cancer (EOGC), diagnosed before the age of 50, exhibits distinct clinicopathological and molecular characteristics compared to late-onset gastric cancer (LOGC). However, the molecular landscape of EOGC remains incompletely defined. This study systematically reviews and meta-analyzes the molecular differences between EOGC and LOGC. Methods: A comprehensive literature search was conducted in PubMed, Embase, and Web of Science to identify studies comparing the molecular features between EOGC and LOGC. Meta-analyses were performed to assess differences in The Cancer Genome Atlas (TCGA) molecular subtypes, frequently mutated genes, key therapeutic biomarkers, and serum tumor markers. Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated, and heterogeneity was evaluated via the I² statistic. Results: EOGC was associated with a significantly greater prevalence of the genomically stable (GS) subtype (OR = 1.71, 95% CI: 1.37–2.12) and a lower prevalence of the chromosomal instability (CIN) subtype (OR = 0.62, 95% CI: 0.50–0.77). CDH1 mutations were more common in EOGC (OR = 3.56, 95% CI: 2.94–4.31), whereas HER2 expression was significantly lower (OR = 0.55, 95% CI: 0.44–0.68). EOGC patients had a lower prevalence of deficient mismatch repair (dMMR)/microsatellite instability-high (MSI-H) (OR = 0.25, 95% CI: 0.12–0.53) but higher PD-L1 expression (OR = 2.11, 95% CI: 1.26–3.54). Serum markers such as CEA (OR = 0.43, 95% CI: 0.36–0.51) and CA19-9 (OR = 0.70, 95% CI: 0.58–0.85) were also less frequently elevated in EOGC. Conclusion: EOGC constitutes a biologically distinct subset of gastric cancer, defined by unique genomic, immune, and serological profiles. These differences highlight the need for age-specific diagnostic and therapeutic strategies and emphasize the value of multiomics approaches to further elucidate the molecular basis of early-onset disease.Keywords
All Related Versions
- Version 1, 2025-05-16, Research Square
- Published version: BMC Cancer, 26 (1).
This publication has 34 references indexed in Scilit:
- Trends, clinicopathological features, surgical treatment patterns and prognoses of early-onset versus late-onset gastric cancer: A retrospective cohort studyJournal of Advanced Research, 2024
- A comparison analysis of the somatic mutations in early-onset gastric cancer and traditional gastric cancerClinics and Research in Hepatology and Gastroenterology, 2024
- Simple IHC reveals complex MMR alternations than PCR assays: Validation by LCM and next‐generation sequencingCancer Medicine, 2022
- Morphologic and molecular analysis of early‐onset gastric cancerCancer, 2020
- Germline CDH1 mutations are a significant contributor to the high frequency of early-onset diffuse gastric cancer cases in New Zealand MāoriFamilial Cancer, 2018
- Gastric cancer patients less than 50 years of age exhibit significant downregulation of E-cadherin and CDX2 compared to older reference populationsAdvances in Medical Sciences, 2014
- COX-2, TFF1, and Src define better prognosis in young patients with gastric cancerJournal of Surgical Oncology, 2013
- Low frequency of HER2 amplification and overexpression in early onset gastric cancerCellular Oncology, 2011
- Clinicopathological characteristics and prognostic analysis of gastric cancer in the young adult in ChinaTumor Biology, 2010
- Clinicopathological aspects and prognostic value with respect to age: An analysis of 3,362 consecutive gastric cancer patientsJournal of Surgical Oncology, 2009